Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

林幸榮 (Shing-Jong Lin)

[Profile]

  • Career and Experience
    Experiences:
  • Medical Expertise
    1. Cardiovascular diseases
    2. Hypertension
    3. Dyslipidemia
    4. Coronary intervention

[Publications]

  1. Tsai SH*, Huang PH, Tsai HY, Hsu YJ, Chen YW, Wang JC, Chen YH, Lin SJ*. Roles of the hypoximir microRNA-424/322 in acute hypoxia and hypoxia-induced pulmonary vascular leakage. FASEB J 2019; (11):12565-12575. 
  2. Kuo CS, Chou RH, Lu YW, Tsai YL, Huang PH*, Lin SJ*. Increased circulating galectin- 1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography. Sci Rep 2020;10(1):1435. 
  3. Huang WP, Yin WH, Chen JS, Huang PH, Chen JW, Lin SJ*. Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway. Sci Rep 2021;11(1):1159. 
  4. Chang CC, Lee YH, Chuang MJ, Hsueh CH, Lu YW, Tsai YL, Chou RH, Wu CH, Lu TM, Huang PH, Lin SJ*, van Geuns RJ. Agreement between invasive wire-based and angiography-based vessel fractional flow reserve assessment on intermediate coronary stenoses. Front Cardiovasc Med 2021 Jun 30;8:707454. 
  5. Chen CY, Leu HB, Wang SC, Tsai SH, Chou RH, Lu YW, Tsai YL, Kuo CS, Huang PH*, Chen JW, Lin SJ*. Inhibition of Trimethylamine N-oxide attenuates neointimal formation through reduction of inflammasome and oxidative stress in a mouse model of carotid artery ligation. Antioxid Redox Signal 2022 17. doi: 10.1089/ars.2021.0115.

限於篇幅,以上謹為代表著作 

回到最上